Inactive Instrument

Company Rock Creek Pharmaceuticals Inc OTC Bulletin Board

Pharmaceuticals

End-of-day quote OTC Bulletin Board
- ^USD	-

20-12-07	Rock Creek Pharmaceuticals, Inc. Went Out of Business	CI
20-02-05	Bankruptcy Judge Changed for Rock Creek Pharmaceuticals, Inc.	CI

Business description: Rock Creek Pharmaceuticals Inc

Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.

Company details: Rock Creek Pharmaceuticals Inc

Rock Creek Pharmaceuticals, Inc.

2040 Whitfield Avenue

34243, Sarasota

+844-727-0727

https://rockcreekpharmaceuticals.com

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+0.08%	-3.33%	+49.41%	+88.31%	1,002B
JOHNSON & JOHNSON	-0.27%	-2.52%	+51.60%	+64.93%	649B
ABBVIE INC.	+0.44%	-4.63%	+18.62%	+67.47%	440B
ROCHE HOLDING AG	-0.80%	-0.43%	+28.92%	+36.94%	346B
NOVARTIS AG	-0.13%	-14.97%	+9.41%	+26.44%	263B
ASTRAZENECA PLC	-1.90%	-2.72%	-2.72%	+10.93%	250B
AMGEN INC.	-0.62%	-11.80%	+39.51%	+49.24%	213B
NOVO NORDISK A/S	-1.06%	-4.23%	-14.70%	-57.76%	201B
GILEAD SCIENCES, INC.	-0.73%	-2.65%	+25.82%	+89.05%	182B
Average	-0.55%	-2.06%	+22.87%	+41.73%	393.74B
Weighted average by Cap.	-0.33%	-2.39%	+31.91%	+55.80%